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Abstract
Objective To assess the effectiveness of a range of weight management
programmes in terms of weight loss.
Design Eight arm randomised controlled trial.
Setting Primary care trust in Birmingham, England.
Participants 740 obese or overweight men and women with a comorbid
disorder identified from general practice records.
Interventions Weight loss programmes of 12 weeks’ duration: Weight
Watchers; Slimming World; Rosemary Conley; group based, dietetics
led programme; general practice one to one counselling; pharmacy led
one to one counselling; choice of any of the six programmes. The
comparator group was provided with 12 vouchers enabling free entrance
to a local leisure (fitness) centre.
Main outcome measures The primary outcome was weight loss at
programme end (12 weeks). Secondary outcomes were weight loss at
one year, self reported physical activity, and percentage weight loss at
programme end and one year.
Results Follow-up data were available for 658 (88.9%) participants at
programme end and 522 (70.5%) at one year. All programmes achieved
significant weight loss from baseline to programme end (range 1.37 kg
(general practice) to 4.43 kg (Weight Watchers)), and all except general
practice and pharmacy provision resulted in significant weight loss at
one year. At one year, only the Weight Watchers group had significantly
greater weight loss than did the comparator group (2.5 (95% confidence
interval 0.8 to 4.2) kg greater loss,). The commercial programmes
achieved significantly greater weight loss than did the primary care
programmes at programme end (mean difference 2.3 (1.3 to 3.4) kg).
The primary care programmes were the most costly to provide.
Participants allocated to the choice arm did not have better outcomes
than those randomly allocated to a programme.
Conclusions Commercially provided weight management services are
more effective and cheaper than primary care based services led by
specially trained staff, which are ineffective.
Trial registration Current Controlled Trials ISRCTN25072883.
Introduction
The World Health Organization has described the increase in
obesity worldwide as a “global epidemic,”
1 and it is associated
with several chronic medical conditions.
2 Obesity is now very
common—for example, almost a quarter of the population of
England are now classified as obese,
3 as defined by the WHO’s
criterion of a body mass index of 30 or above.
1
GuidelinesrecommendthatprimarycarephysiciansinEngland
should identify people with obesity and offer clinical
management,
4 but few options for treatment exist in traditional
primary care settings. One widely available option is a
commercial weight management programme. In some areas,
the English National Health Service offers these services free
to patients, and some evidence supports the effectiveness of
suchprovision.Arandomisedtrialof400overweightandobese
adultsintheUnitedStatesshowedthatpeopleofferedtwoyears’
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Research
RESEARCHfree use of a commercial weight management service lost 2.0
kg,whereasthoseofferedtwoconsultationswithadietitianand
self help resources lost 0.2 kg at the end of two years.
5 (These
figures were calculated according to intention to treat, using
baseline observation carried forward for missing data. Unless
otherwise indicated, all figures quoted in this paper use this
convention.) Another trial comparing a very similar control
group with a different commercially available intervention,
which supplied pre-packaged “diet” foods,
6 had similar
conclusions, with weight loss at one year of 6.6 kg versus 0.7
kg. More recently, a trial offering six months’ free use of
commercial weight loss programmes led to weight loss of 5-6
kg compared with 0.6 kg in the control group, who were asked
not to try to control their weight.
7 Thus good evidence shows
that commercial weight management services can be effective,
butallexistingtrialsinvestigatedtheeffectivenessofprolonged
treatmentprogrammesthatarenotavailableintheEnglishNHS
nor in many other health systems.
Analternative,potentiallywidelyavailable,managementoption
forobesityisforprimarycareteamstotreattheirobesepatients
themselves. A well known primary care programme, the
Counterweight programme, has shown promising results in an
uncontrolledtrial.
8-10However,aclusterrandomisedtrialshowed
that weight loss among obese patients offered treatment by
primary care teams who had received well planned training in
obesity management (4.5 hours’ total training) was less than 1
kgandwassimilartotheweightlossseenincontrolpractices.
11
Therefore, insufficient evidence exists for the effectiveness of
obesity management in primary care.
Wethereforeinvestigatedtheeffectivenessofseveralpragmatic
interventions in primary care patients recruited in the English
NHS. These included more modest entitlement to free
commercialweightlossmanagementprogrammes,primarycare
management, and a minimal intervention control.
Methods
The protocol for the study, describing the study design, is
availableonline.
12LightenUpwasarandomisedcontrolledtrial
withpatientsindividuallyallocatedtooneofeightstudygroups.
We compared six weight loss programmes with a minimal
intervention comparator group provided with 12 vouchers
enabling free entrance to a local leisure (fitness) centre. Three
weight loss programmes were provided by commercial
operators: Weight Watchers, Slimming World, and Rosemary
Conley. Three were provided by the NHS: a group weight loss
programme (Size Down) and two primary care
programmes—nurse led one to one support in general practice
and one to one support by a pharmacist. The final study arm
allowed for participants to choose one of the six interventions.
Population
Eligible participants were registered with general practices in
South Birmingham Primary Care Trust, were aged at least 18
years, and had a raised body mass index recorded in their
primary care notes within the previous 15 months. The body
mass index threshold for invitation was that which makes them
eligible for primary care obesity management services in the
NHS and varied according to ethnic group and the presence or
absence of comorbidities (box 1). The threshold for invitation
forpeoplewithnoobesityrelatedcomorbiditywasabodymass
index of 30 or above. For people of South Asian ethnicity, this
threshold was lower. The general practitioner had to confirm
that the patient had no medical contraindications for any of the
intervention programmes before a letter of invitation was sent.
WeexcludedpatientsiftheywereunabletounderstandEnglish
or were pregnant. Seventeen practices took part.
Recruitment took place from January to May 2009. Eligible
patients were invited to participate in the trial by a standard
letter from their general practitioner, which included the
patients’ information leaflet and a free telephone number for a
call centre managing the recruitment and randomisation. The
nurses at the call centre provided more information to patients
about the trial, collected baseline information, took verbal
consent, and randomised patients to the trial arms. The nurses
then booked participants into their first treatment session and
sent confirmation, along with verification of consent and
information on how to withdraw from the trial if they changed
their minds. Participants allocated to the general practice,
pharmacy, or minimal intervention (comparator) groups were
sent details about how to arrange their first session.
We randomised participants from practices with personnel
trained to provide the practice based weight management
programme (n=7) to all eight arms with a block size of 35,
whereas we randomised people from other practices (n=10) to
oneofsevengroups(excludinggeneralpractice)inablocksize
of 13. An independent statistician prepared two separate
randomisationsequences,and,toensureblinding,theallocations
were placed in opaque, consecutively numbered envelopes,
which the call centre staff used in order. The block sizes were
determined to achieve one to one randomisation across groups,
except for the two primary care arms, for which spaces were
limited and allocation was in a ratio of 1 to 0.7 compared with
the other groups.
Interventions
The participants allocated to the commercial operators Weight
Watchers,SlimmingWorld,andRosemaryConleyhadachoice
of locations and times for the programme.
13-15 Participants were
providedwithvouchersthatexemptedthemfrompayingfor12
consecutive weeks of the programmes. Each programme was
provided in accordance with the respective organisation’s
guidance and ran continuously, with no set start date; the group
leaders were trained by the respective organisations. The trial
participants attended alongside people who paid to attend the
programmes.
TheSizeDownProgrammeisanNHSgroupbasedprogramme
led by food advisers recruited from the local community and
trained by the dietetics department; sessions took place in
various community venues. All members of the group started
together and followed a prescribed course of six sessions, with
follow-up weighing sessions at nine and 12 weeks. Participants
randomised to the general practice or pharmacy arms attended
12 one to one sessions in the general practice or pharmacy.
Appointments were made at a time mutually convenient to the
participant and the nurse/pharmacist. Staff delivering these
programmeshadattendedathreedaytrainingcourseonweight
managementinadultsdeliveredbydietitiansexperiencedinthe
management of obesity. This included key messages on diet
and physical activity, doing a behavioural assessment, goal
setting, plans for change, dealing with resistance, enhancing
motivation, and weight maintenance. It included both practical
tasks and informational components.
Participants allocated to the comparator group were sent
vouchers for 12 free sessions at a local authority run leisure
centre (a council run facility open to all members of the public
and usually consisting of a swimming pool, fitness suite, and
other sports halls or courts). Participants were not given an
appointment to attend and were given no individual advice or
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RESEARCHBox 1: Criteria for invitation to weight loss programmes
• White Europeans and all ethnic groups apart from South Asians with no comorbidities: BMI ≥30
• White Europeans and all ethnic groups apart from South Asians with comorbidities: BMI ≥28
• South Asians with no comorbidities: BMI ≥25
• South Asians with comorbidities: BMI ≥23
BMI=body mass index (kg/m
2)
support on diet or physical activity. Box 2 gives further details
of the interventions, and fuller details are online.
12
Data collection
Baseline data
Baseline weight and height were collected when participants
attended the first session of their weight loss programme or, in
the case of the minimal intervention comparator, at the leisure
centre. Weight was measured without shoes in light clothing.
Assomecommercialprogrammescollectedselfreportedheight,
height was re-measured using a Seca Leicester portable height
measure at the one year follow-up. A researcher contacted
participants who did not attend their first session to obtain a
weightandheightmeasurement.Thecallcentrecollectedother
data at baseline, before randomisation: demographic data,
currentphysicalactivitylevels(usingtheInternationalPhysical
Activity Questionnaire-short form (IPAQ-short)),
16 and use of
weight loss drugs.
Outcome assessment
The primary outcome was weight loss at three months’
follow-up(programmeend).Secondaryoutcomeswerechanges
in self reported physical activity, weight loss at one year, and
percentageweightlossatthreemonthsandoneyear.Follow-up
assessments took place between April 2009 and August 2010.
Attendance at the programmes, apart from the minimal
intervention comparator, was reported by the individual
programme providers. If participants were still attending their
allocatedweightlossinterventionatprogrammeend,theservice
providers weighed them and provided this data to the research
team. We contacted participants who were no longer attending
their allocated programme and offered them follow-up at home
or another convenient location. If participants declined to be
followedupinperson,weaskedthemtoselfreporttheirweight.
TheIPAQ-shortwasre-administeredbyphonetoallparticipants
at three months. We sent participants who had dropped out of
their allocated programme an open ended question asking for
their views about the weight loss programme to which they had
been allocated.
A trained practice nurse, health trainer, or researcher blinded
to the allocation group did the one year assessment at the
participant’sgeneralpracticeorhome.Thisincludedassessment
of weight and height, the IPAQ-short, and a free text question
about their opinion of the service and whether they had tried
any other weight loss programmes or strategies over the course
of the year. The scales used for weight measurement during the
study period in the practices and by the weight management
services were all checked with standardised weights, unless a
record of recent calibration was available.
Sample size
To detect a 2 (SD 3.2) kg difference in weight loss at the three
months’ follow-up between any of the planned interventions
andthecomparatorgroup,with90%powerand5%significance
level and assuming 20% loss to follow-up, we needed 70
participants randomised to each group. The sample size
calculation did not take account of adjustments for multiple
comparisons. To account for dropouts, we allocated 100
participants to each arm, except for the general practice and
pharmacy arms. Because of limited availability, provision of
these programmes was restricted to 70 participants per arm,
resulting in a total sample size of 740 participants. We selected
the2kgdifferenceasbeingachievablefrompreviouspublished
studies,
7 17 and an important contribution towards a 5% weight
loss, which is associated with clinically meaningful health
benefits.
18 19
Analyses
We did all analyses according to intention to treat and using
Statav11.0andSPSSv17.0.Wepreferredobjectivelymeasured
weight, but we used self reported weights when they were the
only measures available. We assumed participants for whom
weight at follow-up was not available to have their baseline
weight for the primary analyses. We also did a sensitivity
analysisusingthelastrecordedweightasthefollow-upweight.
For the outcomes measured on a continuous scale (weight loss,
self reported physical activity), we investigated differences
betweentheseveninterventiongroupsandtheminimalexercise
comparator group by using least squares linear regression.
Between group analyses are expressed as both unadjusted and
adjusted differences (corrected for baseline score for weight
and physical activity, age, sex, and ethnicity). To adjust for
multiple analyses, we applied a Bonferroni correction to each
pair-wise comparison between intervention and control to
maintain a 5% type I error rate across the seven comparisons
made. A secondary pre-specified analysis compared the
outcomes of the commercial weight loss programmes (Weight
Watchers, Slimming World, and Rosemary Conley) with those
oftheprimarycareprogrammes(generalpracticeandpharmacy
based interventions), as these programmes are widely
generalisable.Thisanalysisadjustedfortheclusteringofpatients
within their allocated treatment groups.
We present the proportions of each group that achieved at least
5% weight loss at programme end and one year descriptively.
We examined the effect of choosing a weight loss programme
over being allocated to one by using a regression model that
compared the programme randomised or chosen with the
minimal intervention comparator but additionally included a
single term to assess whether having chosen the programme
hadanadditionalbeneficialeffectoverbeingrandomisedtothe
programme. We extended the model to examine whether any
interactionexistedbetweenindividualprogrammesandchoice.
In an exploratory subgroup analysis, we examined weight loss
separatelyinmenandwomenbyusingaregressionmodel,with
the arm to which they were allocated and age as covariates.
Furthermore, we examined whether the effects of each
intervention varied by sex by adding multiplicative interaction
terms for intervention by sex to the model. This is because
commercial weight loss interventions are almost invariably run
bywomenandtreattheirclientsingroupsdominatedbywomen,
so the effectiveness might vary by sex.
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RESEARCHBox 2: Brief description of interventions
Weight Watchers is group based, and the participant was able to join at any time. One to one support is available for new members and
during weighing. This is followed by a group talk from the leader, with discussion. Meetings took place in community venues and lasted one
hour. Core programme material delivered over five weeks included a food points system (based on age, sex, height, weight, and activity),
beating hunger, taking more physical activity, eating out, and keeping motivated. Other sessions delivered to the whole group covered
recipes, health and nutrition, and keeping active. The plan aims for 500 kcal (2.09 MJ) deficit/day, leading to 0.5-1.0 kg weight loss a week.
Physical activity is encouraged; the objective is to gradually build up to 10 000 steps daily. Predominant strategies used to change behaviour
included stages of change, food and activity diaries, goal setting, and evaluation of progress. Rewards are given for every 3.2 kg (7 lb) lost
and for loss of 5% and 10% of body weight.
Slimming World is group based, and the participant was able to join at any time. Meetings took place in community venues and lasted 90
minutes. Also included is access to a website, magazines, and one to one telephone support from a consultant or other members. Members
are encouraged to eat mainly foods with low energy density to achieve satiety, plus some extras rich in calcium and fibre, with controlled
amounts of high energy dense foods. Weight loss goals are set by the individual. Physical activity is encouraged, with gradual build up to
30 minutes of moderately intense activity five days a week. The theoretical background is based on transactional analysis and motivational
interviewing. Predominant behaviour change strategies used included weekly weighing; group support; and group praise for weight loss,
new decisions, and continued commitment even in the absence of weight loss. Awards are given for 3.2 kg (7 lbs) lost and loss of 10% of
body weight. Individual support, if needed, uses self monitoring of food and emotions, for and against evaluations, visualisation techniques,
and personal eating plans.
Rosemary Conley is group based, and the participant was able to join at any time. Meetings took place in community venues and lasted 90
minutes. One to one support is offered during weighing and to establish a calorie allowance. Additional support is available by email and
telephone. Goals are staged: either 1-1.5 kg/week with a goal of 6.35 kg (1 stone) loss or 0.5-1 kg/week with an initial goal of 3.2 kg (7 lb).
Sessions include a 45 minute optional exercise class. Extra exercise sessions may be offered for an additional fee. The theoretical background
is based on role modelling and group support and uses visualisation and reframing to support behavioural change. Predominant behaviour
change strategies used include rewards for slimmers who maintain or lose weight, slimmer of the week, and certificates for 3.2 kg and 6.35
kg milestones.
The Size Down Programme was an NHS group based programme run in community venues by support workers trained by the dietetics
service. This provided six weekly two hour sessions, with follow-up sessions at nine and 12 weeks. All participants joined together in week
one of the programme. Its particular focus was on long term changes in patterns of eating behaviour, achieving a balanced diet, and increasing
physical activity in daily life, and it used an interactive style. Topics covered included managing behaviour around food and prevention of
relapse, the eatwell plate, nutritional information, planning strategies to deal with lapses into previous dietary behaviours, interactive visual
aids to show the fat and sugar content of foods, and adaptation of recipes. The theoretical background was based on the cycle of change
(Prochaska and Di Clemente). The benefits of physical activity, setting goals, and finding activities to fit into life were discussed. Predominant
behaviour change strategies used included goal setting, stages of change, and self monitoring with a food diary.
The general practice and pharmacy programmes comprised 12 one to one sessions in the general practice or pharmacy. The first session
was planned to last 30 minutes, with follow-up sessions of 15-20 minutes. Sessions were client led and based around a problem solving
approach. Sessions included weight and dieting history, exploration of goals and expectations of patients, the eatwell plate, setting goals to
reduce calorie intake and increase physical activity, planning strategies to deal with challenging situations, use of food diaries, and maintaining
weight loss. Weight loss goals were 5-10% of starting body weight, at a rate of 0.5-1 kg/week over three to six months, followed by maintenance.
Physical activity goals were to aim to slowly increase activity levels to achieve 30 minutes of moderate activity on five days each week. The
theoretical basis used stages of change and motivational interviewing. Predominant behaviour change strategies included goal setting, self
monitoring with food diaries, hunger scale, waist measurements, and physical activity. Resources were provided as homework for discussion
in the next session or for personal reflection. Participants were encouraged to reward themselves for success.
Costs
We ascertained the price to the primary care trust of each
programme and of sending out invitation letters from practices.
We calculated the cost of the call centre that coordinated the
service as an average per person, based on the cost of staff
employed over a 12 month period and the number of clients
who used the service over this time period.
Results
Of the 8810 people invited, 1011 (11.5%) joined the Lighten
Up service (740 as part of the trial and a further 271 in a pilot
or after recruitment to the trial had finished). At programme
end, 658 (88.9%) participants were followed up; 522 (70.5%)
were followed up at one year (fig 1⇓). Table 1⇓ shows the
baseline characteristics of participants. Participants who were
lost to follow-up at programme end tended to be younger than
those who were followed up, but they were similar in terms of
body mass index at the start of the programme, sex, ethnicity,
and index of multiple deprivation score.
Weight loss at programme end
The primary outcome of weight change at programme end was
available for 587 (79.3%) participants, of which 233 (39.7%)
weights were self reported. All programmes, including the
minimal intervention comparator group, achieved statistically
significant weight loss from baseline to the three month end of
programme, with the mean weight loss ranging from 4.4 (SD
4.3) kg (Weight Watchers) to 1.4 (4.1) kg (general practice
provision) in the primary analysis (missing data imputed with
baseline value) (table 2⇓). In the between group analyses, only
the commercial providers (Weight Watchers and Rosemary
Conley) had a statistically significantly greater weight loss and
percentageweightlossthantheexerciseonlycomparator(tables
3⇓ and 4⇓). The findings did not differ when we adjusted the
results for baseline weight, age, sex, or ethnic group. In the
sensitivity analysis (with last recorded value used to impute
missing data), the arm randomised to Slimming World also
achieved a statistically significantly greater weight loss than
the minimal intervention comparator in the unadjusted analysis
(webappendix).Theproportionofparticipantsineacharmwho
achievedatleast5%weightlossatprogrammeendrangedfrom
16% to 46% (between general practice and Weight Watchers)
(table 5⇓).
Weight loss at one year
At one year, follow-up weight was recorded for 503 (68%)
participants, of which 87 (17.3%) weights were self reported.
Statistically significant weight loss from baseline to one year
follow-upoccurredinallgroupsapartfromthoseintheprimary
care arms (general practice and pharmacy) (table 2⇓). In the
betweengroupanalyses,onlytheWeightWatchersarmachieved
a statistically significantly greater weight loss and percentage
weight loss than the exercise only comparator (tables 3⇓ and
4⇓). These findings did not differ in the sensitivity analyses,
when the last recorded weight was used in the imputation (web
appendix). The proportion of participants in each arm who
achieved at least 5% weight loss at one year ranged from 14%
to 31% (between pharmacy and Weight Watchers) (table 5⇓).
At one year, 449 (60.7%) of the sample provided information
about whether they were still trying to lose weight. Of these,
177 (39%) respondents reported continuing to use the weight
loss methods learnt from the programme they were allocated
to; the highest proportions were from those allocated to Size
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RESEARCHDown (n=29; 53%) and Weight Watchers (34; 45%). The
participants who reported continuing to use the methods from
their allocated weight loss programme had lost weight (0.57
(5.6) kg) from programme end to the one year follow-up,
whereas those who had changed to another method had gained
1.17 (5.6) kg and those who had stopped trying to lose weight
had gained 1.18 (6.0) kg (P=0.01).
Per protocol analyses
To determine the weight loss in more adherent participants, we
did a post hoc analysis of weight loss at programme end and at
one year in participants who had started their programme
(n=599). Within group weight loss was slightly higher than for
thewholesamplebutretainedthesamedifferencesbetweenthe
studyarms.Atprogrammeend,withbaselineobservationcarried
forward, the general practice participants still had the lowest
weight loss from baseline (1.91 (95% confidence interval 0.86
to 2.96) kg) and Weight Watchers had the largest weight loss
(4.83 (3.97 to 5.70) kg). We saw a similar picture at one year.
Effect of choice
In the choice arm, 71 (71%) participants chose one of the
commercial providers (Weight Watchers 29 (29%), Slimming
World 14 (14%), Rosemary Conley 28 (28%)), 16 (16%) chose
the Size Down programme, 3 (3%) chose general practice, and
10 (10%) chose pharmacy provision. Women were more likely
than men to choose one of the commercial providers (57 (81%)
v 14 (47%)).
We found no statistically significant difference in weight loss
achieved at programme end or one year follow-up between
participants who chose their programme and those who were
randomised to the same programme (adjusted mean difference
0.19 (95% confidence interval −0.7 to 1.1) kg at programme
end and 0.01 (−1.3 to 1.3) kg at one year. We found no
statistically significant interaction between choice and
programme.
Effect of sex
In adjusted models, sex had no effect on weight loss at
programme end or one year. Nor did we find any statistically
significant interaction between sex and the weight loss
programme.
Commercial programmes versus one to one
primary care programmes
In the pre-specified secondary analysis comparing the
commercial programmes with the primary care programmes,
participantsrandomisedtothecommercialprogrammeslost2.3
(1.3to3.4)kgmorethandidthoseallocatedtotheprimarycare
programmes at programme end (P=0.004). In the analysis
adjusted for age, ethnicity, sex, weight, and physical activity at
baseline, the additional weight loss in the commercial groups
was 2.3 (1.3 to 3.4) kg. At one year, the difference was 1.7 (0.5
to 3.0) kg (P=0.02) unadjusted and 1.6 (0.3 to 2.9) kg (P=0.06)
in the adjusted model. Mean weight loss at one year, with
baseline value used for imputation, was 0.8 (SD 4.7) kg for
primary care and 2.5 (6.2) kg for commercial programmes.
Self reported physical activity
Self reported physical activity increased between baseline and
follow-up in all groups (table 2⇓). The smallest increase in
activitywasinthoseallocatedtothegeneralpracticearm.When
we compared the change in physical activity with that in the
comparator group at programme end, only the pharmacy group
reportedstatisticallysignificantlymoreactivityintheunadjusted
analysis. At one year follow-up, only participants allocated to
Weight Watchers reported more activity than the comparator
group, although this was not statistically significant. Those
allocated to the general practice arm were doing statistically
significantly less physical activity than the comparator group
(table 6⇓).
Attendance at programmes
Figure 2⇓ shows the attendance at the programmes. The
pharmacy and general practice groups had the highest
proportions of participants attending less than 25% of sessions
(54% (n=38) and 44% (31)), whereas Weight Watchers and the
choice groups had the highest proportions attending 50% or
more sessions (70% (70) and 74% (74)). In the open ended
feedback,10participantsallocatedtoRosemaryConleyreported
difficulties with completing the exercise part of the classes
owing to arthritis and other musculoskeletal problems.
Costs
Table 7⇓ shows the costs of the programmes. These include the
costs of the provider’s service and the cost of the searches in
general practice, invitation letters, and provision of call centre
support.
Discussion
For our primary outcome of weight loss at programme end,
although all the interventions resulted in a significant weight
loss from baseline, only participants in the commercially run
programmes (Weight Watchers and Rosemary Conley) had
significantlygreaterweightlossthandidthoseinthecomparator
group.Atoneyearfollow-up,participantsinalltheprogrammes
apart from the one to one programmes in primary care and
pharmacy settings had a significant weight loss from baseline,
butonlythoseallocatedtoWeightWatchershadasignificantly
greater loss than the comparator group. Attendance seemed to
beanimportantfactor;thehighestattendanceratewasinWeight
Watchers and the lowest for the primary care programmes.
Meaning of findings
Although interventions varied in the emphasis that they placed
onphysicalactivity,allgroupsshowedsomeincreaseinphysical
activity. The typical participant did no moderate or vigorous
activity (which does not include walking) at baseline and was
doing 50-60 minutes a week at 12 weeks and about half that at
oneyearfollow-up.Thoseintheexerciseonlycomparatorgroup
were doing a similar amount to participants in other arms. All
interventions therefore seemed to act as a spur for people to do
what they already knew they should be doing, a conclusion that
is supported by qualitative feedback from participants (data not
shown). This activity was probably insufficient to account for
weight loss in the comparator group, and this weight loss
probably represents what might be achieved by people
responding to a spur to action. We believe that the comparator
groupwasthereforeatruecontrolgroup.Thecomparatorgroup
achieved statistically significant weight loss from baseline to
follow-upatbothprogrammeendandoneyear.Thisisprobably
a reflection of the motivation of those people who accepted the
invitation to the weight loss programme. A meta-analysis of
cohort studies showed that over four years of follow-up, obese
people lose weight.
20 The weight loss in our comparator group
wasonlyslightlygreaterthanthis“natural”weightlossobserved
in cohorts receiving no intervention. It is presumably a result
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RESEARCHof efforts by people to lose weight, most of which are unaided
by specific interventions.
Our study shows that 12 week weight management courses are
effective in producing clinically significant weight loss in a
proportion of their clients. Almost a third of people allocated
to the Weight Watchers group achieved a clinically important
5% reduction in body weight at one year follow-up. This level
of weight loss has been shown to reduce the risk of progression
todiabetes.
18 19Othertrialsofcommercialprovidershaveshown
greater weight loss, but these interventions were of longer
duration.
5 21 In a trial in the United Kingdom, Germany, and
Australia,Jebbreporteda4.0kgaverageweightlossafteraone
year Weight Watchers programme,
21 which is only marginally
greater than the 3.5 (SD 6.9) kg loss we found at one year as a
result of a 12 week programme. In the United States, Heshka
and colleagues reported that one year’s free access to Weight
Watchers resulted in a weight reduction of 3.5 kg at one year.
5
Truby and colleagues evaluated a six month programme in a
volunteersamplerecruitedfromanationalmediacampaignand
reported a 6.6 (SD 5.4) kg loss in those allocated to Weight
Watchers and a 6.3 (6.1) kg loss in those allocated to Rosemary
Conley at the six month follow-up.
7 At one year, data were
available only for completers, but with baseline observation
carriedforwardthemeanweightlosswas4.6kgfortheWeight
Watchers and 5.3 kg for the Rosemary Conley groups. The
greater weight loss in these trials suggests that longer
interventions might be somewhat more effective.
We did not find statistically significant benefits from the
programmes in primary care. The Counterweight Project Team
reported promising results from their weight management
programme in primary care in the UK,
8-10 but this was not a
randomised trial. Using baseline observation carried forward,
the mean weight loss at one year in the Counterweight
programme was 1.3 kg, which is slightly greater than the 0.8
kg we report. Hardcastle and colleagues reported statistically
significantweightlossatsixmonths’follow-upinarandomised
controlled trial of a primary care based weight loss programme
compared with a no intervention control, with weight loss of
0.7 kg, similar to our findings.
22 Lower weight loss in general
practice or pharmacies may be due to several factors. Firstly,
although the primary care practitioners were trained in weight
management counselling before the start of Lighten Up, they
had considerably less experience of weight management than
did counsellors/group leaders of other programmes, and this is
one of a multitude of other roles they have in primary care.
Secondly, primary care and pharmacy sessions were one to one
and the dynamic of the group may be an important element in
supporting successful weight loss.
23 Thirdly, feedback from
participantswhodidnotcompletethefullprogrammesuggested
that they had difficulties in arranging convenient sessions so
these often did not occur on a weekly basis, unlike the
commercialprogrammes,whichoccurweeklyataregulartime.
Finally, some evidence suggests that primary care practitioners
have little faith in their ability to effect positive change in their
patients’ weight.
24 Analogous data from smoking cessation
programmes show that primary care based services are less
effective than dedicated cessation services.
25 26 This could
indicate a generic problem with supporting behavioural change
in primary care that needs further investigation.
The proportions of recruited participants who did not start the
programmesvariedconsiderablybetweenthestudygroups.This
maywellberelatedtotheprocessfortakinguptheintervention.
In the primary care programmes and minimal intervention
comparator, participants were provided with details about how
to make their first appointment, whereas for the commercial
programmes participants were booked directly on to a
programme and provided with details of the venue and time of
their first session. The Size Down group was a closed group in
which all participants started together, so some people had to
wait several weeks before a new group started. This may have
accounted for the high proportion who did not start this
programme. This has implications for the planning of future
similar programmes.
Concerns have been raised about whether the commercial
programmes are acceptable to men, as they are generally run
by and attended by women.
21 As with other weight loss
trials,
5 7-10 21 22 27 we had more female participants, so men seem
to be less likely to accept the offer of this form of help.
However, we found no evidence that outcomes were worse for
men attending the commercial group based programmes. We
did assign some of the commercial groups as “male friendly”
so that men would know that there would be other male
attendees, and in the case of a Rosemary Conley class a group
walk was available as an alternative to the group exercise
session. Men in the choice arm were more likely to select the
NHS programmes, including the group based Size Down
programme, possibly because of the female image of the
commercial programmes, although almost half did select a
commercial programme.
Two previous weight loss trials have investigated the effect of
being allocated a choice of intervention. Burke and colleagues
randomised participants either to choose one of two dietary
regimens or to have this allocated randomly.
28 The diets were
equallyeffectiveinpromotingweightloss,butpeoplerandomly
allocated to a diet achieved significantly greater weight loss
than did those allocated to choose their preferred diet (about
3.5 kg greater at 18 months). Renjilian and colleagues
randomised participants to either choose between individual
andgrouptreatmentforweightlossorbeallocatedthetreatment
modality that they did not prefer.
23 The trial showed that group
treatment was more effective than one to one treatment, but the
differences in weight loss between those randomised to choice
and those randomised to receive the modality they did not
chooseweresmallandnon-significant.Takentogetherwithour
results, these data indicate that choice of treatment programme
is not important in the efficacy of weight management
programmes.Aslongaspeoplearepreparedtoparticipate,they
will probably benefit. Promoting choice in health interventions
risks promoting less effective options, as happened here in the
Lighten Up trial. People seem to be unable to choose a
programme for weight management that is more effective for
them than one simply allocated at random.
To illustrate the potential importance to public health of the
effects of the commercial weight loss interventions, we
constructed a life table. Firstly, we calculated the age and sex
specific mortality rates for people of ideal body mass index
frompublishedUKdata(availablefromtheauthors).Secondly,
weappliedthehazardratioforanincreasetoabodymassindex
of 34 (the mean of our trial population).
29 We then used these
rates to produce a life table from age 49 years (the mean age in
the trial). In the most effective intervention, participants lost
1.3 kg/m
2 on average, and we recalculated the life table on the
basis of this reduced body mass index. The difference in life
expectancy was about one year. If we assumed that the people
randomised to this intervention continued to weigh 1.3 kg/m
2
less throughout life, then the cost per life year saved was about
£77 (€88; $122). These benefits are not discounted and make
manyassumptions,buttheyillustratethatthisinterventioncould
be very cost effective, with the critical factor being duration of
maintenance of weight loss. A two year study of a commercial
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2011;343:d6500 doi: 10.1136/bmj.d6500 Page 6 of 16
RESEARCHprogrammeshowedminorweightregaininthesecondyear,but
the intervention was available to participants during that time.
5
More intensive interventions on weight loss in the diabetes
prevention studies have shown a declining but small persistent
advantage over 10 years for those receiving the intensive
intervention,
30 but whether weight loss persists from a 12 week
intervention of the kind we examined is unknown. Given the
potential effect on the population, this is a priority for further
research, as is research on prevention of weight regain.
Strengths and limitations of study
This trial was an evaluation of a range of weight management
programmes in a real service context, and we have shown that
robust evaluation of new services is possible. We kept data
collection to a minimum to encourage people to take part, thus
increasing the generalisability of the results. However, unlike
most other trials,
7-10 21 we have measured self reported physical
activitytodeterminethecontributionthismakestoweightloss.
The population was more diverse than in many previous
trials
8-10 17 31; 13% of the sample were from an ethnic minority
group,morethan30%weremen,and73.4%werefromthetwo
mostsocioeconomicallydisadvantagedfifthsofthepopulation.
The characteristics of our recruited participants reflect the
population of the primary care trust well; 23.5% of the
participants were in the bottom 10% of socioeconomic
deprivation, which is similar to that for the primary care trust,
and the 13% of participants from a minority ethnic group is
slightly lower than the local prevalence of 18%. In one practice
for which data were available, we investigated how the
characteristics of people who were invited differed from those
whojoinedthestudy.Wefoundnodifferenceinethnicity,mean
age, or socioeconomic deprivation, but, as expected, women
were more likely to accept the invitation to take part. Our
follow-up rates at one year compare well with other studies of
weight management interventions, which reduced bias from
attrition.
7-10 21
Our trial has some limitations. It was powered only to compare
individualprogrammeswiththecomparatorgroup,nottomake
head to head comparisons between programmes. Where we
were unable to get an objective weight measurement, we asked
participants to self report. However, we do not believe that this
willhaveledtooverestimationofweightloss,asthosewhoself
reported their weight at the time of predicted programme end
had a smaller weight loss than did those who provided an
objective measure of weight, but some measurement error may
exist. The self reported physical activity seems high and, as
reportedpreviously,
32 33islikelytobeanoverestimate.However,
as we had baseline measures, we are able to present change in
activity, and differences in overestimation between trial arms
are unlikely. To increase the uptake and follow-up rates, we
kept data collection to a minimum, so we do not have data on
health outcomes or on the previous strategies for weight loss
used by the participants. The response rate to the invitation was
11.5%. These are likely to be people who were most motivated
to change. Invitation was by post, and a face to face invitation
in the context of a consultation might result in higher uptake of
the service. Attendance data were provided by the providers of
the weight management programmes and could not be
independentlyvalidated,sotheymaybesubjecttosomeerrors.
The costs that we present are the direct costs of the programme
to the primary care trust; we have not tried to determine cost to
primary care from a change in consultation rates or drugs or the
costs to the participants of attending the programmes or
purchasinganyproductsfromthecommercialprogrammes.We
could not unpick the elements associated with greater weight
loss in people who attended the commercial programmes. This
mighthavebeenduetothegroupbasedapproach,theskillsand
background of the group leaders, the regularity of sessions, or
easy booking for the first session and no scheduling
requirements thereafter.
Conclusion
Our findings suggest that a 12 week group based dedicated
programmeofweightmanagementcanresultinclinicallyuseful
amounts of weight loss that are sustained at one year in an
unselected primary care population with obesity. Interventions
provided by primary care showed no evidence of effectiveness.
Theonlyprogrammetoachievestatisticallysignificantlygreater
weight loss than the comparator group was Weight Watchers.
Further research should explore the optimal duration of such
programmes.
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RESEARCHTables
Table 1| Characteristics of participants at baseline according to intervention arm. Values are numbers (percentages) unless stated otherwise
Exercise/comparator
(n=100)
Choice
(n=100)
Pharmacy
(n=70)
General
practice
(n=70)
Size Down
(n=100)
Rosemary
Conley
(n=100)
Slimming
World (n=100)
Weight
Watchers
(n=100) Characteristics
25 (25) 30 (30) 19 (27) 23 (33) 36 (36) 31 (31) 35 (35) 28 (28) Male sex
49.67 (13.83) 47.45 (14.35) 48.94 (15.82) 50.48 (13.79) 48.75 (15.63) 49.76 (14.51) 48.84 (14.91) 50.71 (14.56) Mean (SD) age (years)
Ethnic group:
84 (84) 83 (83) 61 (87) 63 (90) 91 (91) 83 (83) 88 (88) 87 (87) White British/Irish
3 (3) 1 (1) 0 0 3 (3) 0 3 (3) 1 (1) South Asian
9 (9) 10 (10) 6 (9) 4 (6) 3 (3) 12 (12) 5 (5) 5 (5) Black
British/Caribbean/African
4 (4) 6 (6) 3 (4) 3 (4) 3 (3) 5 (5) 4 (4) 7 (7) Mixed and other
30.46 (13.9) 31.69 (14.2) 35.06 (15.1) 32.19 (15.7) 32.48 (14.2) 35.82 (14.9) 33.27 (15.4) 31.33 (12.6) Mean (SD) index of
multiple deprivation
93.14 (15.13) 91.72 (12.49) 92.81 (13.71) 92.04 (14.75) 95.47 (17.88) 93.72 (13.68) 94.35 (13.38) 93.47 (14.15) Mean (SD) starting weight
(kg)
33.88 (4.4) 33.41 (3.4) 33.44 (3.5) 33.06 (3.5) 33.77 (3.9) 33.38 (3.5) 33.83 (3.8) 33.96 (3.9) Mean (SD) starting BMI
(kg/m
2)
Starting BMI (kg/m
2):
14 (14) 14 (14) 9 (13) 11 (16) 14 (14) 17 (17) 11 (11) 12 (12) <30
48 (48) 54 (54) 35 (50) 39 (56) 51 (51) 49 (49) 51 (51) 51 (51) 30-34
25 (25) 28 (28) 20 (29) 18 (26) 27 (27) 27 (27) 32 (32) 29 (29) 35-39
6 (6) 4 (24) 3 (4) 2 (3) 5 (5) 4 (4) 5 (5) 8 (8) ≥40
474 (0-1168) 571 (0-1427) 457 (0-1481) 530 (0-1733) 758 (0-1565) 386 (0-1121) 687 (0-1422) 614 (0-1447) Median (IQR) physical
activity (kcals/week)
0 (0- 0) 0 (0- 0) 0 (0- 60) 0 (0- 0) 0 (0- 0) 0 (0-0) 0 (0-26.25) 0 (0-0) Median (IQR)
moderate/vigorous
physical activity
(minutes/week)
3 (3) 3 (3) 3 (4) 1 (1) 2 (2) 3 (3) 4 (4) 3 (3) Weight loss drug at
baseline
BMI=body mass index; IQR=interquartile range.
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RESEARCHTable 2| Weight loss (crude and imputed if missing), body mass index reduction, and physical activity change at programme end and one
year follow-up. Values are means (95% CI)
Exercise/comparator Choice Pharmacy
General
practice Size Down
Rosemary
Conley
Slimming
World
Weight
Watchers
Weight loss at programme end (kg)
2.01 (1.2 to 2.8)** 3.32 (2.5 to
4.1)**
2.11 (1.0 to
3.2)**
1.37 (0.4 to 2.3)* 2.38 (1.7 to
3.1)**
4.23 (3.2 to
5.2)**
3.56 (2.7 to
4.4)**
4.43 (3.6 to
5.3)**
BOCF†
2.96 (1.8 to 4.1)** 3.81 (2.9 to 4.7) 2.80 (1.4 to
4.2)**
2.17 (0.7 to 3.7)* 3.22 (2.3 to
4.1)**
5.29 (4.2 to
6.4)**
4.25 (3.3 to
5.2)**
5.15 (4.2 to
6.1)**
Complete
cases only‡
1.87 (1.0 to 2.78)** 3.56 (2.8 to
4.3)**
2.14(1.0 to
3.2,)**
1.13 (0.0 to 2.3) 2.37 (1.7 to
3.1)**
4.37 (3.4 to
5.4)**
3.76 (2.9 to
4.6)**
4.71 (3.9 to
5.6)**
LOCF‡
Physical activity change to programme end (kcal/week)
1608, (988 to 2228)** 1986 (1245 to
2727)**
2720 (1790 to
3649)**
1895 (963 to
2826)**
1480 (701 to
2259)**
1801 (1155 to
2447)**
1899 (1226 to
2571)**
1926 (1225 to
2629)**
BOCF†
1747 (1080 to 2415)** 2159 (1362 to
2955)**
2885 (1912 to
3857)**
1980 (1010 to
2949)**
1542 (733 to
2351)**
1856 (1193 to
2520)**
1957 (1267 to
2648)**
1946 (1238 to
2654)**
Complete
cases only‡
Change in physical activity to programme end (minutes/week)§
51 (36 to 67) 59 (40 to 77) 73 (51 to 94) 47 (25 to 70) 55 (35 to 75) 49 (33 to 65) 60 (42 to 79) 58 (42 to 75) Moderate and
vigorous
7 (−3 to 18) 5 (−6 to 17) 1 (−11 to 14) 12 (−4 to 28) 16 (3 to 29) 14 (2 to 26) 1 (−12 to 13) 7 (−6 to 19) Walking
Weight loss at one year
1.08 (0.1 to 2.1)* 2.15 (0.9 to
3.4)**
0.66 (−0.4 to
1.7)
0.83 (−0.4 to
2.0)
2.45 (1.3 to
3.6)**
2.12 (0.9 to
3.4)**
1.89 (0.9 to
2.9)**
3.46 (2.1 to
4.8)**
BOCF†
1.66 (0.1 to 3.2)* 2.94 (1.2 to
4.7)**
1.19 (−0.7 to
3.1)
1.26 (−0.6 to
3.1)
3.71 (2.0 to
5.4)**
3.27 (1.4 to
5.1)**
3.10 (1.5 to
4.7)**
4.43 (2.7 to
6.1)**
Complete
cases only‡
1.33 (0.2 to 2.4)* 2.96 (1.7 to
4.3)**
1.85 (0.5 to
3.2)*
1.13 (−0.1 to
2.4)
3.10 (1.9 to
4.3)**
3.17 (1.8 to
4.5)**
3.28 (2.2 to
4.4)**
4.35 (3.0 to
5.7)**
LOCF‡
Physical activity change to one year (kcal/week)
1766 (1044 to 2487)** 1642 (837 to
2448)**
1473 (742 to
2203)**
861 (256 to
1467)*
1429 (644 to
2213)**
1429 (657 to
2202)**
1362 (645 to
2078)**
2048 (1262 to
2834)**
BOCF†
1899 (1129 to 2668)** 1659 (846 to
2472)**
1562 (792 to
2332)**
861 (256 to
1467)*
1488 (673 to
2303)**
1473 (678 to
2268)**
1404 (666 to
2141)**
2069 (1276 to
2861)**
Complete
cases only‡
Change in physical activity to one year (minutes/week)§
42 (25 to 60) 32 (14 to 50) 27 (3 to 51) 14 (−6 to 35) 19 (4 to 33) 25 (10 to 40) 21 (3 to 39) 60 (40 to 79) Moderate and
vigorous
−3 (−14 to 8) −2 (−14 to 9) 17 (−0.4 to 34) −12 (−26 to 3) 7 (−7 to 21) −3 (−8 to 13) −9 (−22 to 4) −2 (−15 to 12) Walking
Body mass index reduction at one year (kg/m
2)
0.45 (0.1 to 0.8)* 0.90 (0.5 to
1.3)**
0.31 (0.0 to 0.7) 0.32 (−0.1 to
0.7)
0.67 (0.3 to
1.0)**
0.75 (0.3 to
1.1)**
0.71 (0.4 to
1.0)**
1.17 (0.7 to
1.7)**
BOCF†
0.79 (0.2 to 1.4)* 1.42 (0.8 to
2.1)**
0.73 (−0.1 to
1.6)
0.66 (−0.1 to
1.4)
1.19 (0.5 to
1.8)**
1.33 (−0.6 to
2.0)**
1.36 (0.7 to
2.0)**
1.8 (1.1 to 2.5)** Complete
cases only‡
BOCF=baseline observation carried forward; LOCF=last observation carried forward.
*P<0.05 (paired t test from baseline).
**P≤0.001 (paired t test from baseline).
†Primary analysis.
‡Sensitivity analyses.
§Change from baseline in minutes/week using baseline observation carried forward.
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RESEARCHTable 3| Differences in weight loss at programme end and one year follow-up between intervention groups and comparator arm (exercise
only)
One year Programme end
Intervention
group P value
Adjusted mean
difference* (95% CI) P value
Mean difference
(95% CI) P value
Adjusted mean
difference* (95% CI) P value
Mean difference
(95% CI)
0.024 −2.49 (−4.15 to
−0.83)
0.025 −2.38 (−3.98 to
−0.78)
0.001 −2.34 (−3.56 to
−1.13)
<0.001 −2.41 (−3.60 to
−1.23)
Weight
Watchers
1.000 −0.90 (−2.57 to 0.77) 1.000 −0.81 (−2.41 to
0.78)
0.322 −1.24 (−2.47 to
−0.02)
0.072 −1.55 (−2.74 to
−0.37)
Slimming World
0.798 −1.35 (−3.03 to 0.33) 1.000 −1.05 (−2.64 to
0.55)
0.001 −2.39 (−3.61 to
−1.16)
0.001 −2.22 (−3.40 to
−1.04)
Rosemary
Conley
0.386 −1.65 (−3.33 to 0.04) 0.649 −1.37 (−2.97 to
0.23)
1.000 −0.09 (−1.31 to 1.14) 1.000 −0.37 (−1.55 to
0.82)
NHS Size
Down
1.000 0.12 (−1.96 to 1.72) 1.000 0.25 (−1.51 to 2.01) 1.000 0.61 (−0.73 to 1.96) 1.000 0.65 (−0.66 to 1.95) General
practice
1.000 0.06 (−1.84 to 1.96) 1.000 0.41 (−1.35 to 2.17) 1.000 0.12 (−1.51 to 1.27) 1.000 −0.10 (−1.41 to
1.20)
Pharmacy
0.591 −1.47 (−3.13 to 0.20) 1.000 −1.07 (−2.67 to
0.53)
0.224 −1.33 (−2.55 to
−0.11)
0.216 −1.30 (−2.49 to
−0.12)
Choice
Negative difference favours intervention arm. P values adjusted to maintain overall 5% type 1 error rate across seven comparisons; 95% confidence intervals not
adjusted.
*Adjusted for weight at baseline, physical activity at baseline, age, sex, and ethnic group.
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RESEARCHTable 4| Differences in percentage weight loss at programme end and one year follow-up between intervention groups and comparator
arm (exercise only)
One year Programme end
Intervention
group P value
Adjusted mean
difference* (95% CI) P value
Mean difference
(95% CI) P value
Adjusted mean
difference* (95% CI) P value
Mean difference
(95% CI)
0.022 −2.96 (−4.47 to
−0.91)
0.023 −2.58 (−4.29 to
−0.87)
0.001 −2.47 (−3.74 to
−1.20)
<0.001 −2.53 (−3.76 to
−1.30)
Weight
Watchers
1.000 0.98 (−2.78 to 0.81) 1.000 −0.88 (−2.60 to
0.83)
0.408 −1.24 (−2.52 to 0.04) 0.106 −1.52 (−2.75 to
−0.30)
Slimming World
0.861 −1.41 (−3.21 to 0.38) 1.000 −1.08 (−2.79 to
0.63)
0.002 −2.38 (−3.66 to
−1.09)
0.004 −2.18 (−3.41 to
−0.96)
Rosemary
Conley
0.500 −1.65 (−3.45 to 0.16) 0.965 −1.30 (−3.01 to
0.42)
1.000 0.04 (−1.25 to 1.32) 1.000 −0.17 (−1.40 to
1.06)
NHS Size
Down
1.000 −0.12 (−2.09 to 1.86) 1.000 0.21 (−1.67 to 2.10) 1.000 0.81 (−0.60 to 2.21) 1.000 0.77 (−0.58 to 2.12) General
practice
1.000 −0.05 (−2.08 to 1.99) 1.000 0.36 (−1.53 to 2.25) 1.000 0.01 (−1.44 to 1.46) 1.000 0.00 (−1.36 to 1.35) Pharmacy
0.474 −1.66 (−3.45 to 0.12) 1.000 −1.26 (−2.97 to
0.45)
0.227 −1.39 (−2.67 to
−0.12
0.185 −1.39 (−2.62 to
−0.16)
Choice
Negative difference favours intervention arm. P values adjusted to maintain overall 5% type 1 error rate across seven comparisons; 95% confidence intervals not
adjusted.
*Adjusted for weight at baseline, physical activity at baseline, age, sex, and ethnic group.
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RESEARCHTable 5| Proportion of each group that achieved 5% loss in body weight at programme end and one year follow-up
One year Programme end
Intervention group Relative risk* (95% CI) Percentage (95% CI) Relative risk* (95% CI) Percentage (95% CI)
2.10 (1.03 to 4.28) 31.0 (22.1 to 41.0) 2.98 (1.56 to 5.66) 46.0 (36.0 to 56.3) Weight Watchers
1.22 (0.57 to 2.60) 21.0 (13.5 to 30.3) 1.56 (0.81 to 3.01) 35.0 (25.7 to 45.2) Slimming World
1.81 (0.87 to 3.74) 26.0 (17.7 to 35.7) 2.72 (1.42 to 5.23) 42.0 (32.2 to 52.3) Rosemary Conley
1.39 (0.66 to 2.93) 21.0 (13.5 to 30.3) 0.63 (0.30 to 1.33) 18.0 (11.0 to 26.9) NHS Size Down
0.94 (0.40 to 2.22) 15.7 (8.1 to 26.4) 0.62 (0.27 to 1.41) 15.7 (8.1 to 26.4) General practice
0.95 (0.39 to 2.30) 14.3 (7.1 to 24.7) 0.87 (0.39 to 1.94) 21.4 (12.5 to 32.9) Pharmacy
2.01 (0.98 to 4.11) 28.0 (19.5 to 37.9) 1.81 (0.94 to 3.49) 35.0 (25.7 to 45.2) Choice
1.0 17.0 (10.2 to 25.8) 1.0 22.0 (14.3 to 31.4) Exercise/comparator
Analyses use baseline observation carried forward.
*Adjusted for physical activity at baseline, weight at baseline, age, sex, and ethnic group.
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RESEARCHTable 6| Differences in self reported physical activity at programme end and one year follow-up between intervention groups and comparator
arm (exercise only)
One year Programme end
Intervention
group P value
Adjusted mean
difference* in
kcal/week (95% CI) P value
Mean difference in
kcal/week (95% CI) P value
Adjusted mean
difference* in
kcal/week (95% CI) P value
Mean difference in
kcal/week (95% CI)
1.000 233 (−795 to 1260) 1.000 282 (−740 to 1304) 1.000 298 (−688 to 1284) 1.000 319 (−676 to 1314) Weight
Watchers
1.000 −325 (−1361 to 710) 1.000 −404 (−1426 to 618) 1.000 −299 (−694 to 1293) 1.000 291 (−704 to 1285) Slimming
World
1.000 −640 (−1678 to 398) 1.000 −336 (−1359 to 686) 1.000 4 (−1000 to 992) 1.000 193 (−802 to 1188) Rosemary
Conley
1.000 −258 (−1299 to 782) 1.000 −337 (−1359 to 685) 1.000 −144 (−1142 to 854) 1.000 −127 (−1122 to 868) NHS Size
Down
1.000 −849 (−1990 to 292) 0.808 −904 (−2031 to 222) 1.000 238 (−856 to 1333) 1.000 287 (−809 to 1383) General
practice
1.000 −345 (−1521 to 831) 1.000 −293 (−1420 to 833) 0.133 1350 (−222 to 2479) 0.328 1112 (16 to 2208) Pharmacy
1.000 −254 (−1285 to 777) 1.000 −123 (−1146 to 899) 1.000 228 (−762 to 1217) 1.000 378 (−617 to 1373) Choice
Positive difference favours intervention arm. P values adjusted to maintain overall 5% type 1 error rate across seven comparisons; 95% confidence intervals not
adjusted.
*Adjusted for weight at baseline, physical activity at baseline, age, sex, and ethnic group.
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RESEARCHTable 7| Costs of interventions
Total cost* (£) Provider’s costs (£) Intervention
76.87 55.00 Weight Watchers
71.37 49.50 Slimming World
76.87 55.00 Rosemary Conley
91.87 70.00 NHS Size Down
112.73 90.86 General practice
112.3 90.43 Pharmacy
*Cost per participant recruited includes £10 for call centre, £3.54 for practices to run search of their lists and for general practitioners to screen lists for ineligible
participants, and £8.33 for invitation letters sent by practices (£1 per letter, with 12% response rate).
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RESEARCHFigures
Fig 1 Flow of participants through trial. *Includes both objectively measured and self reported weight
Fig 2 Proportion of scheduled weight loss programme sessions attended
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RESEARCH